Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee

NCT00435292 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Naproxen
DIETARY_SUPPLEMENT: flavocoxid 250 mg
DIETARY_SUPPLEMENT: flavocoxid 500 mg

Sponsor

Primus Pharmaceuticals